Identification of pyrazole derivative as an antiviral agent against chikungunya through HTVS

Surender Singh Jadav, Barij Nayan Sinha, Boris Pastorino, Xavier De Lamballerie, Rolf Hilgenfeld, Venkatesan Jayaprakash*

*Corresponding author for this work
14 Citations (Scopus)


Structure based High-throughput Virtual Screening (HTVS) of ChikV nsP2 protease (PDB: 3TRK) with two publicly available database ZINC12 and BindingDB has been carried out to identify suitable inhibitors for the treatment of chikungunya infection. HTVS protocol implemented in GLIDE 5.0 (Schrodinger LLC) has been employed to screen the drug-like subset of ZINC12 (10,090,210) and protease inhibitors in BindingDB (83,000). One of the chemical scaffolds from the list of different chemical classes was selected for the synthesis of (ZINC04725220, compound 11). Few more schiff's bases (13-21) were also synthesized with the intermediate 1,3-diphenyl-1H-pyrazole-4-carbaldehyde (4-6) and tested for anti-ChikV (strain OPY1, Reunion Island 2006) activity using Cytopathic effect reduction (CPE) assay. Surprisingly, only compound 11(IC50: 5..g/ml ie 14.15 ..M) has shown inhibitory activity against ChikV. Further precise docking of compound 11 with target protein was carried out to understand the molecular interactions important for activity.

Original languageEnglish
JournalLetters in Drug Design and Discovery
Issue number4
Pages (from-to)292-301
Number of pages10
Publication statusPublished - 2015

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'Identification of pyrazole derivative as an antiviral agent against chikungunya through HTVS'. Together they form a unique fingerprint.

Cite this